The group with a higher percentage of reactivity was RA (23%), while the RA-ILD group was 20%; the most frequent anti-HLA for both groups were DR4, DR8, DR12, and DQ9 antigens. This evidence concerns the gene TNFRSF10A and rheumatoid arthritis.